Topical vs. Oral Finasteride: matching delivery to tolerance

Finasteride is the most-studied oral medication for androgenetic alopecia, with more than two decades of data behind it. The trade-off has always been the same: it works because it suppresses dihydrotestosterone (DHT) systemically — and a minority of men report sexual, mood, or cognitive side effects from that systemic suppression.

Topical finasteride is the newer answer to that trade-off. It's designed to hit the scalp where miniaturization happens while keeping serum DHT closer to baseline. Below is what the clinical data actually says, and how to think about matching route to tolerance.

How finasteride works, in plain English

Androgenetic alopecia is driven largely by DHT binding to androgen receptors on genetically susceptible scalp follicles. DHT shortens the anagen (growth) phase and progressively miniaturizes hairs until they no longer produce visible pigmented shafts.

Finasteride inhibits type II 5-alpha reductase, the enzyme that converts testosterone to DHT. Oral finasteride 1 mg daily suppresses serum DHT by roughly 65–70% and scalp DHT by a similar magnitude (Drake et al., J Am Acad Dermatol, 1999).

That scalp DHT reduction is the mechanism. The systemic DHT reduction is the source of most side-effect complaints.

What the oral data actually shows

Oral finasteride 1 mg has the strongest long-term evidence in hair medicine. The pivotal five-year study in men aged 18–41 showed hair count increases versus placebo maintained through year five, with 90% of treated men showing no further visible loss (Kaufman et al., Eur J Dermatol, 2002).

Side-effect rates in the original trials were modest: decreased libido in ~1.8%, erectile dysfunction in ~1.3%, ejaculation disorder in ~1.2%, versus roughly 1% for each in placebo. Real-world reporting is higher and more variable, and a subset of patients describe persistent symptoms after discontinuation — a phenomenon still debated in the literature but taken seriously by clinicians.

Mood effects (low mood, anhedonia, brain fog) are reported less commonly but are the reason many patients ask about the topical route in the first place.

What topical finasteride changes

Topical finasteride is applied directly to the scalp, typically as a solution or gel. The key pharmacology finding: it can achieve scalp DHT suppression comparable to oral dosing while producing meaningfully lower serum DHT reduction.

A randomized, controlled, multi-country trial published in 2023 compared topical finasteride 0.25% spray to oral finasteride 1 mg over 24 weeks. Change in target-area hair count was non-inferior between the two arms. Serum DHT dropped ~34% with topical versus ~56% with oral (Piraccini et al., J Eur Acad Dermatol Venereol, 2022).

Smaller studies and pharmacokinetic work have shown similar patterns: scalp target hit, systemic exposure reduced but not eliminated.

The point of topical finasteride is not zero systemic exposure — it's less systemic exposure at equivalent scalp effect.

That distinction matters. Topical is not a workaround for anyone who cannot tolerate any DHT suppression. It's a way to shift the ratio.

Who tends to do well on oral

Oral finasteride remains the default for most patients because:

• The efficacy data is deeper and longer (5+ years of RCT follow-up).
• Compliance is easier — one tablet, no drying time, no interaction with styling products.
• Cost is typically lower.
• It pairs cleanly with oral minoxidil or topical minoxidil in combination protocols.

If you have no history of sexual dysfunction, no mood disorder that concerns you, and want the most-studied option, oral is a reasonable starting point.

{callout: The core trade-off} Oral finasteride has the deepest efficacy data and easiest compliance; topical finasteride offers comparable scalp results with roughly half the systemic DHT suppression — choose based on how much systemic exposure you want to accept.

Who tends to do better on topical

Topical finasteride is worth considering if:

• You've tried oral finasteride and developed sexual, mood, or cognitive side effects.
• You have baseline sexual dysfunction or a mood condition and want to minimize systemic androgen shifts.
• You're planning a family in the near term and want to reduce (not eliminate) systemic exposure — note that finasteride is still contraindicated in pregnancy regardless of route, so partner safety around handling the solution matters.
• You want to combine with topical minoxidil in a single application step (some formulations do this).

The honest caveat: topical finasteride still enters systemic circulation. Patients with prior severe reactions to oral finasteride should discuss whether any 5-ARI exposure is appropriate.

What a workup looks like before you commit

Hair loss protocols don't require labs to start, but a thoughtful workup improves decision-making — especially if you're weighing route against side-effect risk. The markers worth having on file include:

• Total and free testosterone — baseline for interpreting any future sexual side-effect complaints.
• DHT — baseline for confirming suppression is happening if results stall.
• TSH, free T4 — thyroid dysfunction mimics and worsens hair shedding.
• Ferritin — low iron stores are a common overlooked cause of diffuse shedding, particularly relevant if you notice general thinning rather than a classic pattern.
• Vitamin D, zinc — supportive markers.
• CBC and CMP — general screen.

If you choose to run labs through us, those are the markers we look at first when someone is deciding between oral, topical, or combination therapy. If you don't, a clinician can still evaluate symptoms, family history, and scalp pattern to guide the choice.

Practical differences you'll notice day to day

Oral finasteride: one tablet daily. No application step. No interaction with styling. Effects on hair take 3–6 months to become visible, with peak response around 12 months.

Topical finasteride: applied to the scalp once daily (formulation-dependent). Requires dry-time before styling. Can be irritating for a subset of users — scalp itch or dryness is the most common local complaint. Timeline to visible response is similar.

Both routes require ongoing use. Discontinuation leads to loss of gains within 6–12 months in most patients, because the underlying androgen sensitivity of the follicles doesn't change.

Combining with minoxidil

Regardless of finasteride route, minoxidil remains the other pillar of medical hair regrowth. It works through a different mechanism (potassium channel opening, prolonged anagen phase, improved follicular blood flow) and the two are additive.

Combination oral finasteride plus topical or oral minoxidil consistently outperforms either monotherapy in real-world dermatology practice, and combination topical formulations (finasteride + minoxidil in one solution) simplify compliance for patients who prefer a single application.

The honest summary

Oral finasteride: strongest evidence, easiest compliance, higher systemic DHT suppression.

Topical finasteride: comparable scalp efficacy in the head-to-head data available, lower systemic DHT suppression, but not zero — and the long-term dataset is shorter.

Both are legitimate options. The right one is the one you'll actually take consistently for years, with a side-effect profile you can live with. A clinician who reviews your symptoms, history, and — if you have them — your labs can help match the route to your tolerance rather than defaulting you into whichever prescription is easiest to write.

Compounded topical finasteride formulations are not FDA-approved as finished products; see our medication disclaimer for details on how compounding works and what that means for you.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.